Dr. Neytman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 W 41st Street
Suite 217
Miami, FL 33140Phone+1 305-760-8756Fax+1 305-760-8759
Education & Training
Mount Sinai Medical Center of FloridaResidency, Internal Medicine, 2000 - 2003
Nova Southeastern University College of Osteopathic MedicineClass of 2000
Certifications & Licensure
FL State License 2003 - 2026
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease Start of enrollment: 2021 Nov 03
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 6 citationsPhase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19.Babafemi O Taiwo, Kara W Chew, Carlee Moser, David Alain Wohl, Eric S Daar
The Journal of Infectious Diseases. 2023-07-14 - 5 citationsSafety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinic...Rachel A Bender Ignacio, Kara W Chew, Carlee Moser, Judith S Currier, Joseph J Eron
JAMA Network Open. 2023-04-03 - 2 citationsOne Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial.Nikolaus Jilg, Kara W Chew, Mark J Giganti, Eric S Daar, David A Wohl
Clinical Infectious Diseases. 2023-10-05
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
